NeuroSigma, Inc. (NeuroSigma), a California -based life sciences company focused on commercialization of its non-invasive Monarch ™ eTNS™ System for the treatment of neurological and neuropsychiatric disorders, today announced that the U.S. ...
Read MoreDuring the past three decades since its invention, PCR has evolved to become one of the fundamental technology platforms in life sciences sector. The application segments of this platform are still expanding, driven by the expiry of key PCR ...
Read MoreDeepResearchReports.com offers 2014 Research Report on Global and China Molecular Diagnostics Equipment Industry, a 231 pages market intelligence premium study published in August 2014 . This research offers 16 company profiles along with 180+ ...
Read MoreAged care industry to be a key revenue source Malaysia is turning out to be the new healthcare investor destination as a proactive government and burgeoning aging population fuel the demand for healthcare services. In 2013, Forbes ranked it as ...
Read MoreSubscribe to our Free Newsletters!